217 related articles for article (PubMed ID: 20089518)
21. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
Stebbins A; Mehta RH; Armstrong PW; Lee KL; Hamm C; Van de Werf F; James S; Toftegaard-Nielsen T; Seabra-Gomes R; White HD; Granger CB;
Circ Cardiovasc Interv; 2010 Oct; 3(5):414-22. PubMed ID: 20858863
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
24. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
[TBL] [Abstract][Full Text] [Related]
26. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
27. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study.
Shiomi H; Nakagawa Y; Morimoto T; Furukawa Y; Nakano A; Shirai S; Taniguchi R; Yamaji K; Nagao K; Suyama T; Mitsuoka H; Araki M; Takashima H; Mizoguchi T; Eisawa H; Sugiyama S; Kimura T;
BMJ; 2012 May; 344():e3257. PubMed ID: 22623632
[TBL] [Abstract][Full Text] [Related]
28. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
[TBL] [Abstract][Full Text] [Related]
29. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
30. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study.
Qiu JP; Zhang Q; Lu JD; Wang HR; Lin J; Ge ZR; Zhang RY; Shen WF
Chin Med J (Engl); 2011 Mar; 124(6):805-10. PubMed ID: 21518584
[TBL] [Abstract][Full Text] [Related]
31. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).
Gierlotka M; Gasior M; Wilczek K; Hawranek M; Szkodzinski J; Paczek P; Lekston A; Kalarus Z; Zembala M; Polonski L
Am J Cardiol; 2011 Feb; 107(4):501-8. PubMed ID: 21195380
[TBL] [Abstract][Full Text] [Related]
32. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
33. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
Patti G; Bárczi G; Orlic D; Mangiacapra F; Colonna G; Pasceri V; Barbato E; Merkely B; Edes I; Ostojic M; Wijns W; Di Sciascio G
J Am Coll Cardiol; 2011 Oct; 58(15):1592-9. PubMed ID: 21958886
[TBL] [Abstract][Full Text] [Related]
34. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up.
Montalescot G; Antoniucci D; Kastrati A; Neumann FJ; Borentain M; Migliorini A; Boutron C; Collet JP; Vicaut E
Eur Heart J; 2007 Feb; 28(4):443-9. PubMed ID: 17251257
[TBL] [Abstract][Full Text] [Related]
35. Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock.
Marcolino MS; Simsek C; de Boer SP; van Domburg RT; van Geuns RJ; de Jaegere P; Akkerhuis KM; Daemen J; Serruys PW; Boersma E
Cardiology; 2012; 121(1):47-55. PubMed ID: 22378251
[TBL] [Abstract][Full Text] [Related]
36. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
Toma M; Buller CE; Westerhout CM; Fu Y; O'Neill WW; Holmes DR; Hamm CW; Granger CB; Armstrong PW;
Eur Heart J; 2010 Jul; 31(14):1701-7. PubMed ID: 20530505
[TBL] [Abstract][Full Text] [Related]
37. The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI.
Leone AM; Sgueglia GA; Porto I; Niccoli G; Burzotta F; Trani C; De Caterina AR; Buffon A; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):775-82. PubMed ID: 22048665
[TBL] [Abstract][Full Text] [Related]
38. Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.
Tjandrawidjaja MC; Fu Y; Westerhout CM; White HD; Todaro TG; Van de Werf F; Mahaffey KW; Wagner GS; Granger CB; Armstrong PW;
Eur Heart J; 2010 Mar; 31(5):573-81. PubMed ID: 19952006
[TBL] [Abstract][Full Text] [Related]
39. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
[TBL] [Abstract][Full Text] [Related]
40. Outcome of emergency percutaneous coronary intervention for acute ST-elevation myocardial infarction complicated by cardiac arrest.
Mager A; Kornowski R; Murninkas D; Vaknin-Assa H; Ukabi S; Brosh D; Battler A; Assali A
Coron Artery Dis; 2008 Dec; 19(8):615-8. PubMed ID: 19005296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
